Author/Authors :
Mamoru Hashimoto، نويسنده , , Toru Imamura، نويسنده , , Satoshi Tanimukai، نويسنده , , Hiroaki Kazui، نويسنده , , Etsuro Mori، نويسنده ,
Abstract :
Donepezil has been licensed for use in Japan to improve cognitive function since 1999. Among 94 patients with probable Alzheimerʹs disease who we treated with donepezil, seven patients developed urinary incontinence, although this event was transient in most patients.
